Stelmakh Edward

CIK 00018870461 companyWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001887046

Recent Transactions

42 trades

Exercise/Conversion
OptimizeRx Corp$OPRX
Restricted Stock Units
2025-12-19−5,237→ 5,237 total
Sale
OptimizeRx Corp$OPRX
Common Stock
2025-12-19$13.51/sh−1,388→ 126,830 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2025-12-19+5,237→ 128,218 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2025-10-03+16,623→ 127,387 total
Tax Payment
OptimizeRx Corp$OPRX
Common Stock
2025-10-03$18.75/sh−4,406→ 122,981 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Restricted Stock Units
2025-10-03−16,623→ 0 total
Award
OptimizeRx Corp$OPRX
Common Stock
2025-08-21+15,625→ 110,764 total
Award
OptimizeRx Corp$OPRX
Stock Option
2025-08-21+35,156→ 35,156 total
Tax Payment
OptimizeRx Corp$OPRX
Common Stock
2025-02-15$6.64/sh−2,156→ 95,139 total
Award
OptimizeRx Corp$OPRX
Common Stock
2024-12-23+41,408→ 97,295 total
Award
OptimizeRx Corp$OPRX
Stock Option
2024-12-23+77,742→ 77,742 total
Tax Payment
OptimizeRx Corp$OPRX
Common Stock
2024-12-19$4.75/sh−1,316→ 37,287 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2024-12-19+5,237→ 38,603 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Restricted Stock Units
2024-12-19−5,237→ 10,474 total
Tax Payment
OptimizeRx Corp$OPRX
Common Stock
2024-10-11$6.63/sh−2,066→ 33,366 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2024-10-11+8,222→ 35,432 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Restricted Stock Units
2024-10-11−8,222→ 0 total
Tax Payment
OptimizeRx Corp$OPRX
Common Stock
2024-10-03$7.83/sh−4,177→ 27,210 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2024-10-03+16,622→ 31,387 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Restricted Stock Units
2024-10-03−16,622→ 16,583 total
Award
OptimizeRx Corp$OPRX
Common Stock
2024-02-15+0→ 33,365 total
Award
OptimizeRx Corp$OPRX
Common Stock
2024-02-15+7,083→ 14,765 total
Tax Payment
OptimizeRx Corp$OPRX
Common Stock
2023-10-11$7.15/sh−2,066→ 29,537 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common
2023-10-11+8,221→ 28,034 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2023-10-11+6,155→ 31,603 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Restricted Stock Units
2023-10-11−8,221→ 8,222 total
Tax Payment
OptimizeRx Corp$OPRX
Common Stock
2023-10-03$7.06/sh−4,117→ 17,227 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Restricted Stock Units
2023-10-03−16,662→ 33,205 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2023-10-03+16,662→ 21,344 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2022-10-11+8,221→ 11,221 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Restricted Stock Units
2022-10-11−8,221→ 16,443 total
Tax Payment
OptimizeRx Corp$OPRX
Common Stock
2022-10-11$15.17/sh−6,539→ 4,682 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Restricted Stock Units
2022-10-11−8,221→ 16,443 total
Tax Payment
OptimizeRx Corp$OPRX
Common Stock
2022-10-11$15.17/sh−3,539→ 7,682 total
Exercise/Conversion
OptimizeRx Corp$OPRX
Common Stock
2022-10-11+8,221→ 25,448 total
Award
OptimizeRx Corp$OPRX
Stock Option
2022-10-03+97,637→ 97,637 total
Award
OptimizeRx Corp$OPRX
Restricted Stock Units
2022-10-03+49,867→ 49,867 total
Purchase
OptimizeRx Corp$OPRX
Common Stock
2022-08-15$15.43/sh+3,000→ 3,000 total
Award
OptimizeRx Corp$OPRX
Stock Option
2021-10-11+25,191→ 25,191 total
Award
OptimizeRx Corp$OPRX
Restricted Stock Units
2021-10-11+24,664→ 24,664 total
Award
OptimizeRx Corp$OPRX
Stock Option
0023-12-19+15,711→ 15,711 total
Award
OptimizeRx Corp$OPRX
Restricted Stock Units
0023-12-19+15,711→ 15,711 total

Companies

OptimizeRx Corp
CFO/COO
$OPRX

Recent Filings

Address

C/O OPTIMIZERX CORPORATION 260 CHARLES STREET, SUITE 302

WALTHAM, MA, 02453

View on SEC.gov